ArticleCancer chemotherapy and pharmacology2013

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors.

Ruth Plummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.